Lantern Pharma shares are trading higher after the company reported better-than-expected Q3 GAAP EPS results.
Portfolio Pulse from Benzinga Newsdesk
Lantern Pharma's shares are trading higher following the company's announcement of better-than-expected Q3 GAAP EPS results.
November 09, 2023 | 6:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lantern Pharma's stock is trading higher due to better-than-expected Q3 GAAP EPS results.
Lantern Pharma's Q3 GAAP EPS results exceeded expectations, which is a positive signal for investors. This has led to an increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100